SETD2 LOSS CONTRIBUTES TO CHRONIC MYELOID LEUKEMIA PROGRESSION AFFECTING DNA INTEGRITY AND EPIGENETIC LANDSCAPE

被引：0
|
作者：
Mancini, M. [1 ]
De Santis, S. [2 ]
Monaldi, C. [2 ]
Bruno, S. [2 ]
Taccini, A. C. [2 ]
Castagnetti, F. [2 ]
Gugliotta, G. [1 ]
Iurlo, A. [3 ]
Cerrano, M. [4 ]
Galimberti, S. [5 ]
Balducci, S. [5 ]
Cavo, M. [1 ,2 ]
Soverini, S. [1 ]
机构：
[1] Univ Bologna, IRCCS Azienda Osped, Ist Ematol Seragnoli, Bologna, Italy
[2] Univ Bologna, Dipartimento Sci Med Chirurg, Bologna, Italy
[3] Fdn IRCCS Ca Granda Osped Policlin, UO Oncoematol, Milan, Italy
[4] AOU Citta Salute Sci Torino, Turin, Italy
[5] Univ Pisa, Clin & Expt Med, Hematol, Pisa, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P020
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [21] Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells
    Sheng, Yaru
    Ji, Zhongzhong
    Zhao, Huifang
    Wang, Jinming
    Cheng, Chaping
    Xu, Weimin
    Wang, Xue
    He, Yuman
    Liu, Kaiyuan
    Li, Li
    Voeltzel, Thibault
    Maguer-Satta, Veronique
    Gao, Wei-Qiang
    Zhu, Helen He
    CELL PROLIFERATION, 2019, 52 (04)
  • [22] RECURRENT LOSS OF FUNCTION OF THE SETD2 GENE IN AGGRESSIVE SYSTEMIC MASTOCYTOSIS AND MAST CELL LEUKEMIA
    Soverini, S.
    Mancini, M.
    De Benedittis, C.
    Zazzeroni, L.
    Papayannidis, C.
    Guadagnuolo, V.
    Calogero, R.
    Zago, E.
    Scandola, A.
    Garonzi, M.
    Savini, P.
    Pagano, L.
    Zanotti, R.
    Perbellini, O.
    Bonadonna, P.
    Specchia, G.
    Merante, S.
    Elena, C.
    Gangemi, D.
    Grifoni, F. I.
    Ferrarini, A.
    Delledonne, M.
    Valent, P.
    Cavo, M.
    Rondoni, M.
    Martinelli, G.
    HAEMATOLOGICA, 2015, 100 : 110 - 111
  • [23] AURORA KINASE A/MDM2-MEDIATED SETD2 LOSS OF FUNCTION IN CHRONIC MYELOID LEUKEMIA PATIENTS IN BLAST CRISIS INDUCES GENETIC INSTABILITY AND CAN BE THERAPEUTICALLY TARGETED
    Mancini, M.
    De Santis, S.
    Monaldi, C.
    Bavaro, L.
    Martelli, M.
    Castagnetti, F.
    Gugliotta, G.
    Rosti, G.
    Iurlo, A.
    Abruzzese, E.
    Salvucci, M.
    Pregno, P.
    Gozzini, A.
    Crugnola, M.
    Albano, F.
    Bonifacio, M.
    Calistri, E.
    Tiribelli, M.
    Binotto, G.
    Imovilli, A.
    Trabacchi, E.
    Galimberti, S.
    Barate, C.
    Tenti, E.
    Baccarani, M.
    Martinelli, G.
    Cavo, M.
    Soverini, S.
    HAEMATOLOGICA, 2019, 104 : 23 - 24
  • [24] LOSS OF FUNCTION OF THE SETD2 TUMOR SUPPRESSOR IS A RECURRENT EVENT IN ADVANCED-PHASE CHRONIC MYELOID LEUKEMIA, IS DUE TO POST-TRANSLATIONAL MECHANISMS AND FOSTERS GENETIC INSTABILITY
    Mancini, M.
    De Santis, S.
    Monaldi, Cecilia
    Bavaro, L.
    Martelli, M.
    Castagnetti, F.
    Gugliotta, G.
    Rosti, G.
    Iurlo, A.
    Abruzzese, E.
    Salvucci, M.
    Pregno, P.
    Gozzini, A.
    Crugnola, M.
    Albano, F.
    Bonifacio, M.
    Calistri, E.
    Tiribelli, M.
    Binotto, G.
    Imovilli, A.
    Trabacchi, E.
    Galimberti, S.
    Barate, C.
    Tenti, E.
    Baccarani, M.
    Cavo, M.
    Martinelli, G.
    Soverini, S.
    HAEMATOLOGICA, 2018, 103 : S47 - S47
  • [25] SETD2 detection may reveal response to induction therapy and survival profile in acute myeloid leukemia patients
    Liu, Hui
    HEMATOLOGY, 2023, 28 (01)
  • [26] SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
    Yunzhu Dong
    Xinghui Zhao
    Xiaomin Feng
    Yile Zhou
    Xiaomei Yan
    Ya Zhang
    Jiachen Bu
    Di Zhan
    Yoshihiro Hayashi
    Yue Zhang
    Zefeng Xu
    Rui Huang
    Jieyu Wang
    Taoran Zhao
    Zhijian Xiao
    Zhenyu Ju
    Paul R. Andreassen
    Qian-fei Wang
    Wei Chen
    Gang Huang
    Leukemia, 2019, 33 : 2585 - 2598
  • [27] SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
    Dong, Yunzhu
    Zhao, Xinghui
    Feng, Xiaomin
    Zhou, Yile
    Yan, Xiaomei
    Zhang, Ya
    Bu, Jiachen
    Zhan, Di
    Hayashi, Yoshihiro
    Zhang, Yue
    Xu, Zefeng
    Huang, Rui
    Wang, Jieyu
    Zhao, Taoran
    Xiao, Zhijian
    Ju, Zhenyu
    Andreassen, Paul R.
    Wang, Qian-fei
    Chen, Wei
    Huang, Gang
    LEUKEMIA, 2019, 33 (11) : 2585 - 2598
  • [28] SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis
    De Santis, Sara
    Mancini, Manuela
    Monaldi, Cecilia
    Bruno, Samantha
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Rosti, Gianantonio
    Dan, Elisa
    Sinigaglia, Barbara
    Iurlo, Alessandra
    Abruzzese, Elisabetta
    Pregno, Patrizia
    Albano, Francesco
    Bonifacio, Massimiliano
    Tiribelli, Mario
    Binotto, Gianni
    Galimberti, Sara
    Baccarani, Michele
    Martinelli, Giovanni
    Cavo, Michele
    Soverini, Simona
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S329 - S330
  • [29] Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
    Wang, Suwei
    Yuan, Xiaoqing
    Liu, Yazhen
    Zhu, Kewei
    Chen, Peng
    Yan, Han
    Zhang, Daoyu
    Li, Xi
    Zeng, Hui
    Zhao, Xielan
    Chen, Xiaoping
    Zhou, Gan
    Cao, Shan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [30] Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
    Suwei Wang
    Xiaoqing Yuan
    Yazhen Liu
    Kewei Zhu
    Peng Chen
    Han Yan
    Daoyu Zhang
    Xi Li
    Hui Zeng
    Xielan Zhao
    Xiaoping Chen
    Gan Zhou
    Shan Cao
    Journal of Translational Medicine, 17
12345